<DOC>
	<DOCNO>NCT00239954</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness , safety tolerability escitalopram combination treatment compare single treatment , placebo patient major depressive disorder .</brief_summary>
	<brief_title>Escitalopram Combination Comparison Study Adult Patients With Major Depressive Disorder</brief_title>
	<detailed_description>Both active drug test , alone combination , study currently available antidepressant . However , dos use study lower standard approve dos .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Patients must meet Diagnostic Statistical Manual , Fourth Edition ( DSMIV ) diagnostic criterion Major Depressive Disorder The patient 's current depressive episode must least 12 week duration . Women pregnant , woman breastfeed study , woman childbearing potential practicing reliable method birth control . Patients currently meet DSMIV criterion : a. bipolar disorder ; b. schizophrenia psychotic disorder ; c. obsessivecompulsive disorder ; d. mental retardation pervasive developmental disorder cognitive disorder . Patients consider suicide risk . Patients history seizure disorder , history seizure , stroke , significant head injury , condition predisposes toward risk seizure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>